What is Proxima?
Proxima Bio is a biotechnology firm dedicated to pioneering innovative biological solutions and therapeutics. The company harnesses advanced life sciences research, focusing on cutting-edge biotechnology platforms, molecular biology, and drug discovery to develop novel treatments for a spectrum of diseases. Proxima Bio's research and development efforts are geared towards translating biological insights into potential therapeutic interventions, aiming to address unmet medical needs across various therapeutic areas and improve patient outcomes. The company operates within the biopharmaceutical industry, striving to advance scientific understanding and develop practical therapeutic solutions.
How much funding has Proxima raised?
Proxima has raised a total of $80M across 1 funding round:
Seed
$80M
Seed (2026): $80M with participation from NVentures, AIX Ventures, Magnetic Ventures, and DCVC Management
Key Investors in Proxima
NVentures
NVentures is an upstream exploration firm providing technical and commercial intelligence for the E&P and Energy industry, with a focus on subsurface context, renewables, and business development opportunities.
AIX Ventures
AIX Ventures is a venture capital firm specializing in seed-stage AI startups, partnering with top AI practitioners to transform industries through innovative ideas and long-term founder collaboration.
Magnetic Ventures
Magnetic Ventures is a female-founded venture capital firm that partners with early-stage founders leveraging AI, machine learning, and next-gen biotech for healthcare innovation, providing capital and hands-on support.
What's next for Proxima?
The recent major strategic investment signals a pivotal growth phase for Proxima Bio. This capital is expected to accelerate the company's research and development pipeline, potentially enabling further clinical trials, expansion of its therapeutic focus areas, and the scaling of its innovative biotechnology platforms. The backing from prominent investors suggests confidence in Proxima Bio's long-term vision to translate complex biological discoveries into impactful treatments for challenging medical conditions, positioning the company for significant advancements in the biopharmaceutical landscape.
See full Proxima company page
